Detailed information for compound 38477

Basic information

Technical information
  • TDR Targets ID: 38477
  • Name: 4-[3-cyano-5-(4-fluorophenyl)pyrazol-1-yl]ben zenesulfonamide
  • MW: 342.348 | Formula: C16H11FN4O2S
  • H donors: 1 H acceptors: 4 LogP: 2.27 Rotable bonds: 3
    Rule of 5 violations (Lipinski): 1
  • SMILES: N#Cc1nn(c(c1)c1ccc(cc1)F)c1ccc(cc1)S(=O)(=O)N
  • InChi: 1S/C16H11FN4O2S/c17-12-3-1-11(2-4-12)16-9-13(10-18)20-21(16)14-5-7-15(8-6-14)24(19,22)23/h1-9H,(H2,19,22,23)
  • InChiKey: UUGSJYRNELHGOL-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 4-[3-cyano-5-(4-fluorophenyl)-1-pyrazolyl]benzenesulfonamide

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Mus musculus prostaglandin-endoperoxide synthase 2 Starlite/ChEMBL References
Homo sapiens prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Brugia malayi Blistered cuticle protein 3 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Onchocerca volvulus 0.0063 0.5 0.5
Onchocerca volvulus Chorion peroxidase homolog 0.0063 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Onchocerca volvulus Peroxidasin homolog 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Onchocerca volvulus 0.0063 0.5 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Onchocerca volvulus Peroxidase homolog 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0063 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0063 0.5 0.5
Schistosoma mansoni peroxidasin 0.0063 0.5 0.5
Echinococcus granulosus peroxidasin 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Onchocerca volvulus Peroxidasin homolog 0.0063 0.5 0.5
Onchocerca volvulus 0.0063 0.5 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0063 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0063 0.5 0.5
Brugia malayi Animal haem peroxidase family protein 0.0063 0.5 0.5
Onchocerca volvulus Dual oxidase homolog 0.0063 0.5 0.5
Brugia malayi Peroxidasin 0.0063 0.5 0.5
Schistosoma mansoni peroxidasin 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Loa Loa (eye worm) blistered cuticle protein 3 0.0063 0.5 0.5
Loa Loa (eye worm) animal heme peroxidase 0.0063 0.5 0.5
Onchocerca volvulus Peroxidase homolog 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0063 0.5 0.5
Echinococcus multilocularis peroxidasin 0.0063 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
ED50 (functional) = 0.51 mg kg-1 Effective dose was determined in vivo in male lewis rats by rat adjuvant-induced arthritis assay ChEMBL. 9135032
ED50 (functional) = 7.5 mg kg-1 Effective dose was determined in vivo in male Dawley rats by rat carrageenan-induced foot pad edema assay ChEMBL. 9135032
ED50 (functional) = 67.1 mg kg-1 Effective dose was determined in vivo in male Dawley rats by rat carrageenan-induced hyperalgesia assay ChEMBL. 9135032
IC50 (binding) > 4 Inhibitory activity against prostaglandin G/H synthase 1 (COX-1) ChEMBL. 12383007
IC50 (binding) = 6.47 Inhibition of human Prostaglandin G/H synthase 2 ChEMBL. 11563921
IC50 (binding) = 6.47 Inhibitory activity against prostaglandin G/H synthase 2 (COX-2) ChEMBL. 12383007
IC50 (binding) = 0.34 uM Inhibitory concentration against human prostaglandin G/H synthase 2 at 25 degrees. ChEMBL. 11814774
IC50 (binding) = 0.34 uM In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2) ChEMBL. 9135032
IC50 (binding) = 0.34 uM Inhibitory concentration against human prostaglandin G/H synthase 2 at 25 degrees. ChEMBL. 11814774
IC50 (binding) = 0.34 uM In vitro inhibitory concentration required to block human recombinant prostaglandin G/H synthase 2 (COX-2) ChEMBL. 9135032
IC50 (binding) > 100 uM In vitro inhibitory concentration required to block recombinant human prostaglandin G/H synthase 1 (COX-1) ChEMBL. 9135032
IC50 (binding) > 100 uM In vitro inhibitory concentration required to block recombinant human prostaglandin G/H synthase 1 (COX-1) ChEMBL. 9135032
Ki (binding) = 2.58 Inhibitory constant against prostaglandin G/H synthase 2 (COX-2) ChEMBL. 12383007
Ki (binding) = 1.44 Inhibitory constant against prostaglandin G/H synthase 1 (COX-1) ChEMBL. 12383007
Ki (binding) = 2.58 Inhibitory constant against prostaglandin G/H synthase 2 (COX-2) ChEMBL. 12383007
Log IC50 (binding) < 4 Inhibitory activity against prostaglandin G/H synthase 1 (COX-1) ChEMBL. 12383007
Log IC50 (binding) = 6.47 Inhibition of human Prostaglandin G/H synthase 2 ChEMBL. 11563921
Log IC50 (binding) = 6.47 Inhibitory activity against prostaglandin G/H synthase 2 (COX-2) ChEMBL. 12383007
Selectivity (binding) > 2.47 Selectivity as log (IC50[COX-1]/IC50[COX-2]). ChEMBL. 12383007
Ulceration (functional) = 0 % Percent ulceration was determined in rats at a dose of 200 mg/kg (10 animals) ChEMBL. 9135032

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

4 literature references were collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.